Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
The dopamine receptor DRD2 has been identified as a novel therapeutic target to remodel the immunosuppressive tumour microenvironment by promoting M1 macrophage polarisation, inhibiting the NF-B signalling pathway, and inducing pyroptosis in breast cancer cells [62], which provides a promising new treatment direction for breast cancer
Fang Y, Xu X, Ding J, Yang L, Doan MT, Karmaus PWF, et al
What compounds are commonly compared with GHK-Cu
GHK-Cu (copper peptide)
US$ 27.96
US$ 22.81
US$ 22.98
US$ 28.40
